Otsuka Pharmaceutical Development & Commercialization, Inc. and Otsuka Pharmaceutical Co., Ltd. (Otsuka) today announced that the U.S. Food and Drug Administration (FDA) has granted approval of ...
1d
Autonomix Medical Demonstrates Renal Nerve Sensing and Neural Activity Change in Preclinical Study
Data demonstrate the ability to detect, localize and confirm changes in renal neural activity, supporting continued development of ...
Tuberculosis meningitis treatment may be approaching a turning point: a Cincinnati Children's-led study in Nature Communications finds semaglutide — the diabetes drug sold as Ozempic — outperforms ...
The company has also strengthened its leadership team with two key additions. Clara Cambon-Thiebaud joins as Vice President, Regulatory Affairs, based in New York, and Céline Breda as Vice President, ...
Jideytro is FDA-approved for adult patients with locally advanced or metastatic ROS1-positive NSCLC who received prior ROS1 TKI therapy.
The NIH 4D Nucleome consortium, of which this study is a part, aims to extend this kind of mapping into the fourth dimension: ...
2don MSN
Two ways to read a genome: Body-wide, single-cell atlas maps DNA folding and methylation together
Every cell in the human body carries the same 3 billion letters of DNA, yet a neuron, a heart muscle cell and a pancreatic beta cell each use that shared code to do entirely different jobs. How cells ...
A drug included in one of the pharmaceutical industry’s largest acquisitions this year is starting to paying dividends for GSK, winning a speedy regulatory nod that continues the pharmaceutical ...
UF's Dr. Norman Beatty pursues diseases capable of inflicting much suffering — and becoming more of a threat in a changing ...
The FDA approved zidesamtinib for metastatic ROS1-positive NSCLC following prior kinase inhibitor therapy, offering hope for patients with resistance. The US Food and Drug Administration (FDA) has ...
FDA approval covers post–ROS1 inhibitor locally advanced/metastatic ROS1-positive NSCLC, granted ahead of the September 18, 2026 PDUFA date with breakthrough therapy and orphan drug designations.
For years, scientists have known that the heart has its own network of nerves, the intrinsic cardiac nervous system (ICNS), ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results